Marlborough insulin delivery company CeQur announced Tuesday it had raised $115 million in equity financing.
The company said it will use the funds to advance commercial plans towards a limited market release this year of its CeQur Simplicity wearable insulin device. The three-day device delivers daily injections and can help patients follow their insulin regimens, according to the company. It is both cleared by the U.S. Food and Drug Adminstration and CE-marked by European regulators.
Swiss bank division Credit Suisse Entrepreneur Capital Ltd. and Swiss private equity firm Endeavour Vision led the financing.
